Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Bone marrow transplantation may allow doctors to give higher doses
of chemotherapy and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with thiotepa,
carboplatin, and topotecan followed by bone marrow transplantation in treating patients who
have metastatic or progressive rare cancer.